Recruiting
Spinal cord injury
RecruitingInvestigationalNo placebo
A study testing Wharton's jelly-derived mesenchymal stem cells with spinal cord stimulation for adults with chronic spinal cord injury
InvestigationalNo placebo
- Disease:Spinal cord injury
- Substances:ALLOGENEIC VIABLE WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS, EX-VIVO EXPANDED
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:ALLOGENEIC VIABLE WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS, EX-VIVO EXPANDED
- Sponsor:Fundacio Institut Guttmann



